Megestrol recalls

The FDA has published 4 recalls involving Megestrol since 2018. The latest was reported on 7 Jun 2023. Most were for potency & assay. Mckesson Packaging Services has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls4since 2018

Last 12 months0reported

Class I00% of total

Ongoing1latest 7 Jun 2023

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 50%Class III 2 50%

Why megestrol is recalled

Potency & Assay375%
Packaging Defects125%

Companies

By year

2023125%
2018375%

Ongoing megestrol recalls

1 active

Reported	Class	Recall	Company	Reason	Where
7 Jun 2023Drug	CLASS II	Megestrol Acetate Oral Suspension, USP 40 mg/mL recalled by Akorn	Akorn	Potency & Assay	Nationwide

All megestrol recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
7 Jun 2023Drug	CLASS II	Megestrol Acetate Oral Suspension, USP 40 mg/mL recalled by Akorn	Akorn	Potency & Assay	Nationwide
21 Nov 2018Drug	CLASS III	Megestrol Acetate Oral Suspension, USP 625 mg recalled	Breckenridge Pharmaceutical	Potency & Assay	Nationwide
12 Sep 2018Drug	CLASS II	Megestrol Acetate Oral Suspension, USP 400 mg/mL UD cups in boxes recalled	Mckesson	Packaging Defects	Nationwide
14 Feb 2018Drug	CLASS III	Megestrol Acetate Oral Suspension, USP 400 mg/ UD cups in boxes recalled	Mckesson Packaging Services	Potency & Assay	Nationwide

Should you stop taking Megestrol?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.